Interleukin-1 in cerebral ischemia

Keio Journal of Medicine

Volumn 45, Issue 3, 1996, Pages 230-238

  Betz, A Lorris ^a   Schielke, Gerald P ^b   Yang, Guo Yuan ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PFIZER INC   (United States)

Author keywords

focal cerebral ischemia; interleukin receptor antagonist; interleukin 1 ; knockout mice; zinc protoporphyrin

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

BRAIN INJURY; BRAIN ISCHEMIA; CONFERENCE PAPER; DRUG ACTIVITY; GENE EXPRESSION; MOUSE; NONHUMAN;

EID: 0029836252     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.45.230     Document Type: Conference Paper

References (102)

1. Dinarello CA: The Biology of Interleukin-1, Basel, Karger, 1992
2. Blatteis CM, Dinarello CA, Shibata M, Llanos-QJ, Quan N, Busija D: Does circulating interleukin-1 enter the brain? In: Mercer JB, ed, Thermal Physiology, Amsterdam, Elsevier, 1989; 385-390
3. Breder CD, Dinarello CA, Saper CB: Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240: 321-324
4. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S: Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res 1990; 514: 135-140
5. Giulian D, Tapscott MJ: Immunoregulation of cells within the central nervous system. Brain Behav Immun 1988; 2: 352-358
6. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, Barone FC, Feurestein GZ: Interleukin-1 β mRNA expression in ischemic rat cortex. Stroke 1993; 24: 1746-1751
7. Fontana A, Weber E, Dayer JM: Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol 1984; 133: 1696-1698
8. Blatteis CM: Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1. Int J Neurosci 1988; 38: 223-232
9. Banks WA, Ortiz L, Plotkin SR, Kastin AJ: Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991; 259: 988-996
10. Ban E, Milon G, Prudhomme N, Fillion G, Haour F: Receptors for interleukin-1 (α and β) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 1991; 43: 21-30
11. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336-340
12. Takao T, Tracey DE, Mitchell WM, De Souza EB: Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 1990; 127: 3070-3078
13. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652
14. Farrar WL, Kilian PL, Ruff MR, Hill JM, Pert CB: Visualization and characterization of interleukin-1 receptors in brain. J Immunol 1987; 139: 459-463
15. Sunder SK, Becker KJ, Cierpial MA, Carpenter MD, Rankin LA, Fleener SL, Ritchie JC, Simson PE, Weiss JM: Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 1989; 86: 6398-6402
16. Kent S, Bluthe RM, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ, Vannice JL: Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin-1. Proc Natl Acad Sci USA 1992; 89: 9117-9120
17. Kuriyama K, Hori T, Mori T, Nakashima T: Actions of interferon α and interleukin-1β on the glucose-responsive neurons in the ventromedial hypothalamus. Brain Res Bull 1990; 24: 803-810
18. Nakashima T, Hori T, Mori T, Kuriyama K, Mizuno K: Recombinant human interleukin-1β alters the activity of preoptic thermo-sensitive neurons in vitro. Brain Res Bull 1989; 23: 209-213
19. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M: Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 1990; 181: 323-326
20. A receptor function in brain. Mol Pharmacol 1991; 39: 105-108
21. Plata-Salaman CR, Ffrench-Mullen JM: Interleukin-1β depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull 1992; 29: 221-223
22. Di Julio N, Urrutia A, Gruol DL. Interleukin-1 β increases intracellular calcium and alters the electrophysiology of cultured cerebellar Purkinje neurons. Soc Neurosci 1991; 17: 1197
23. Kluger MJ, ed: Fever and Sepsis, London, Wiley, 1990
24. Kluger MJ: Fever: role of pyrogens and cryogens. Physiol Rev 1991; 71: 93-127
25. Rothwell NJ: Mechanisms of the pyrogenic actions of cytokines. Eur Cytokine Netw 1990; 1: 211-213
26. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H: Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238: 524-526
27. McCarthy DO, Kluger MJ, Vander AJ: Suppression of food intake during infection: is interleukin-1 involved? Am J Clin Nutr 1985; 42: 1179-1182
28. Plata-Salaman CR, Ffrench-Mullen JM: Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1β. Physiol Behav 1992; 51: 1277-1279
29. Cornell RP, Schwartz DB: Central administration of interleukin-1 elicits hyperinsulinemia in rats. Am J Physiol 1989; 256: R772-R777
30. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB: Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Ncurosci 1988; 8: 2485-2490
31. Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM: Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991; 87: 1360-1366
32. De Simoni MG, Sironi M, de Luigi A, Manfridi A, Mantovani A, Ghezzi P: Intracerebroventricular injection of interleukin-1 induces high circulating levels of interleukin-6. J Exp Med 1990; 171: 1773-1778
33. Busbridge NJ, Dascombe MJ, Tilders FJ, van Oers JW, Linton EA, Rothwell NJ: Central activation of thermogenesis and fever by interleukin-1β and interleukin-1α involves different mechanisms. Biochem Biophys Res Commun 1989; 162: 591-596
34. Clark BD, Bedrosian I, Schindler R, Cominelli F, Cannon JG, Shaw AR, Dinarello CA: Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 1991; 71: 2412-2418
35. Higgins GA, Olschowka JA: Induction of interleukin-1β mRNA in adult rat brain. Brain Res Mol Brain Res 1991; 9: 143-148
36. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M: Convulsants induce interleukin-1β messenger RNA in rat brain. Biochem Biophys Res Commun 1990; 171: 832-837
37. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M: Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus. Neurosci Lett 1991; 123: 254-256
38. McClain CJ, Cohen D, Ott L, Dinarello CA, Young B: Ventricular fluid interleukin-1 activity in patients with head injury. J Lab Clin Med 1987; 110: 48-54
39. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T: Local production of tumour necrosis factor α, interleukin 1 and interleukin 6 in meningococcal meningitis. J Exp Med 1989; 170: 1859-1867
40. Merrill JE, Chen IS: HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991; 5: 2391-2397
41. 4L Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611-7615
42. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M: Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J Neurochem 1992; 58: 390-392
43. Yabuuchi K, Minami M, Katsumata S, Yamazaki A, Satoh M: An in situ hybridization study on interleukin-1β mRNA induced by transient forebrain ischemia in the rat brain. Brain Res Mol Brain Res 1994; 26: 135-142
44. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ: Concomitant cortical expression of TNF-α and IL-1β mRN As follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 1994, 23: 103-114
45. Wiessner C, Gehrmann J, Lindholm D, Topper R, Kreutzberg GW, Hossmann KA: Expression of transforming growth factor-β1 and interleukin-1β mRNA in rat brain following transient fore-brain ischemia. Acta Neuropathol 1993; 86: 439-446
46. Szaflarski J, Burtrum D, Silverstein FS: Cerebral hypoxiaischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995; 26: 1093-1100
47. Buttini M, Sauter A, Boddeke HW: Induction of interleukin-1 β mRNA after focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 1994; 23: 126-134
48. Bauer J, Berkenbosch F, Van Dam AM, Dijkstra CD: Demonstration of interleukin-1β in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol 1993; 48: 13-21
49. Rothwell NJ, Relton JK: Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc Brain Metab Rev 1993; 5: 178-198
50. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K: Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995; 26: 676-681
51. Yamasaki Y, Suzuki T, Yamaya H, Matsuura N, Onodera H, Kogure K: Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci Lett 1992; 142: 45-47
52. Nagai H, Kitagaki K, Kuwabara K, Koda A: Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na). Agents Actions 1992; 37: 273-283
53. Bashir ZI, Henley JM: The French connection: a magnum of excitatory amino acids in Marseilles. Trends Pharmacol Sci. 1993; 14: 387-390
54. Kadoya C, Domino EF, Yang GY, Stern JD, Betz AL: Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke 1995; 26: 1035-1038
55. Paschen W, Uto A, Djuricic B, Schmitt J: Hemeoxygenase expression after reversible ischemia of rat brain. Neurosci Lett 1994; 180: 5-8
56. Takeda A, Onodera H, Sugimoto A, Itoyama Y, Kogure K, Shibahara S: Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 1994; 666: 120-124
57. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP: Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991; 266: 10331-10336
58. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341-346
59. Andersson J, Bjork L, Dinarello CA, Towbin H, Andersson U: Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992; 22: 2617-2623
60. Garcia JH, Liu KF, Relton JK: Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995; 147: 1477-1486
61. Licinio J, Wong ML, Gold PW: Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology 1991; 129: 562-564
62. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC: Interleukin-1 receptor antagonist is a member of the interleukin-1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 1991; 88: 5232-5236
63. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992; 29: 243-246
64. Martin D, Chinookoswong N, Miller G: The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994; 130: 362-367
65. Betz AL, Yang GY, Davidson BL: Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 1995; 15: 547-551
66. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J: Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995; 80: 401-411
67. Busto R, Dietrich WD, Globus MY, Valdés I, Scheinberg P, Ginsberg MD: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987; 7: 729-738
68. Morikawa E, Rosenblatt S, Moskowitz MA: L-arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia. Br J Pharmacol 1992; 107: 905-907
69. Relton JK, Strijbos PJ, O'Shaughnessy CT, Carey F, Forder RA, Tilders FJ, Rothwell NJ: Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med 1991; 174: 305-310
70. Rothwell NJ: Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci 1991; 12: 430-436
71. Dascombe MJ, Hardwick A, Lefeuvre RA, Rothwell NJ: Impaired effects of interleukin-1β on fever and thermogenesis in genetically obese rats. Int J Obes 1989; 13: 367-373
72. Morimoto K, Morimoto A, Nakamori T, Tan N, Minagawa T, Murakami N: Cardiovascular responses induced in free-moving rats by immune cytokines. J Physiol 1992; 448: 307-320
73. Rothwell NJ: CRF is involved in the pyrogenic and thermogenic effects of interleukin-1β in the rat. Am J Physiol 1989; 256: E111-E115
74. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W: Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522-524
75. Lyons MK, Anderson RE, Meyer FB: Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury. Brain Res 1991; 545: 339-342
76. Betz AL: Oxygen free radicals and the brain microvasculature. In: Pardridge WM, ed, The Blood-Brain Barrier. Cellular and Molecular Biology, New York, Raven Press, 1993; 303-321
77. Kirsch JR, Helfaer MA, Lange DG, Traystman RJ: Evidence for free radical mechanisms of brain injury resulting from ischemia/ reperfusion-induced events. J Neurotrauma 1992; 9(Suppl): S157-S163
78. Farooqui AA, Horrocks LA: Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res Brain Res Rev 1992; 16: 171-191
79. Hu ZY, Wong SC, He YY, Doster SK, Xu J, Hsu CY: Expression of IL-1β, TNF, and IL-6 mRNAs in the ischemic cerebral cortex. Soc Neurosci 1994; 20: 615
80. Kim JS, Gautam SC, Chopp M, Zaloga C, Jones ML, Ward PA, Welch KM: Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 1995; 56: 127-134
81. Liu T, Young PR, McDonnell PC, White RF, Barone FC, Feuerstein GZ: Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett 1993; 164: 125-128
82. Wood PL: Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 1995; 17: 242-248
83. Barone FC, Hillegass LM, Price WJ, White RF, Lee EV, Feuerstein GZ, Sarau HM, Clark RK, Griswold DL: Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 1991; 29: 336-345
84. Hallenbeck JM, Dutka AJ: Background review and current concepts of reperfusion injury. Arch Neurol 1990; 47: 1245-1254
85. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367-1379
86. Strieter RM, Kunkel SL, Showell HJ: Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS, and IL-1β. Science 1989; 243: 1467-1469
87. Wong D. Dorovini Zis K: Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 1992; 39: 11-21
88. Wang X, Siren AL, Liu Y, Yue TL, Barone FC, Feuerstein GZ: Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res Mol Brain Res 1994; 26: 61-68
89. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ: P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994; 25: 202-211
90. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR: Postischemic administration of an anti-mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 1994; 25: 869-876
91. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM, Anderson DC: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995; 26: 1438-1443
92. Katabami T, Shimizu M, Okano K, Yano Y, Nemoto K, Ogura M, Tsukamoto T, Suzuki S, Ohira K, Yamada Y, et al: Intracellular signal transduction for interleukin-1 β-induced endothelin production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1992; 188: 565-570
93. Barone FC, Globus MY, Price WJ, White RF, Storer BL, Feuerstein GZ, Busto R, Ohlstein EH: Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14: 337-342
94. Yamashita K, Kataoka Y, Niwa M, Shigematsu K, Himeno A, Koizumi S, Taniyama K: Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischemia: histochemical evidence. Cell Mol Neurobiol 1993; 13: 15-23
95. McCarron RM, Wang L, Stanimirovic DB, Spatz M: Endothelin induction of adhesion molecule expression on human brain microvacular endothelial cells. Neurosci Lett 1993; 156: 31-34
96. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385-388
97. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883-1885
98. Lazarewicz JW, Wroblewski JT, Palmer ME, Costa E: Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 1988; 27: 765-769
99. Lynch G, Kessler M, Arai A, Larson J: The nature and causes of hippocampal long-term potentiation. Prog Brain Res 1990; 83: 233-250
100. Miller B, Sarantis M, Traynelis SF, Attwell D: Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355: 722-725
101. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15: 53-59
102. Murphy S, Pearce B: Eicosanoids in the CNS: sources and effects. Prostaglandins Leukot Essent Fatty Acids 1988; 31: 165-170